SC
PFE icon

Saturna Capital’s Pfizer PFE Stock Holding History

Saturna Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-442,650
Closed -$11.7M – 153
2024
Q4 		$11.7M Sell
442,650
-335,500
-43% -$9.1M 0.16% 54
2024
Q3 		$22.5M Sell
778,150
-23,050
-3% -$672K 0.29% 55
2024
Q2 		$22.4M Sell
801,200
-300,030
-27% -$8.26M 0.3% 54
2024
Q1 		$30.6M Buy
1,101,230
+30
+0% +$832 0.42% 56
2023
Q4 		$31.7M Sell
1,101,200
-57,405
-5% -$1.74M 0.49% 54
2023
Q3 		$38.4M Sell
1,158,605
-4,043
-0.3% -$143K 0.68% 50
2023
Q2 		$42.6M Buy
1,162,648
+10,645
+0.9% +$414K 0.74% 49
2023
Q1 		$47M Sell
1,152,003
-18,493
-2% -$799K 0.91% 45
2022
Q4 		$60M Sell
1,170,496
-329
-0% -$15.8K 1.29% 34
2022
Q3 		$51.2M Sell
1,170,825
-50,054
-4% -$2.43M 1.25% 31
2022
Q2 		$64M Buy
1,220,879
+630
+0.1% +$32.1K 1.51% 22
2022
Q1 		$63.2M Buy
1,220,249
+5,360
+0.4% +$278K 1.27% 29
2021
Q4 		$68.5M Buy
1,214,889
+690
+0.1% +$34.2K 1.23% 28
2021
Q3 		$52.2M Buy
1,214,199
+696
+0.1% +$30.8K 1.05% 31
2021
Q2 		$47.5M Buy
1,213,503
+3,650
+0.3% +$142K 0.97% 37
2021
Q1 		$43.8M Buy
1,209,853
+11,272
+0.9% +$400K 0.98% 39
2020
Q4 		$44.1M Sell
1,198,581
-50,436
-4% -$1.85M 1% 37
2020
Q3 		$43.5M Sell
1,249,017
-19
-0% -$666 1.11% 37
2020
Q2 		$38.8M Sell
1,249,036
-180
-0% -$6.12K 1.09% 40
2020
Q1 		$43.4M Sell
1,249,216
-6,640
-0.5% -$226K 1.4% 30
2019
Q4 		$46.7M Buy
1,255,856
+1,117
+0.1% +$39.8K 1.26% 36
2019
Q3 		$42.8M Buy
1,254,739
+1,282
+0.1% +$46.6K 1.24% 37
2019
Q2 		$51.5M Sell
1,253,457
-14,345
-1% -$570K 1.51% 26
2019
Q1 		$51.1M Buy
1,267,802
+7,818
+0.6% +$313K 1.49% 24
2018
Q4 		$52.2M Buy
1,259,984
+211
+0% +$8.76K 1.76% 16
2018
Q3 		$52.7M Sell
1,259,773
-106
-0% -$4.08K 1.53% 24
2018
Q2 		$43.4M Hold
1,259,879
– – 1.39% 32
2018
Q1 		$42.4M Sell
1,259,879
-653
-0.1% -$22.4K 1.35% 34
2017
Q4 		$43.3M Buy
1,260,532
+5,896
+0.5% +$201K 1.33% 36
2017
Q3 		$42.5M Buy
1,254,636
+3,651
+0.3% +$117K 1.38% 37
2017
Q2 		$39.9M Buy
1,250,985
+301
+0% +$9.49K 1.32% 37
2017
Q1 		$40.6M Buy
1,250,684
+4,237
+0.3% +$134K 1.38% 33
2016
Q4 		$38.4M Sell
1,246,447
-527
-0% -$16.1K 1.35% 35
2016
Q3 		$40.1M Sell
1,246,974
-527
-0% -$17.6K 1.31% 31
2016
Q2 		$41.7M Sell
1,247,501
-3,066
-0.2% -$97.9K 1.33% 30
2016
Q1 		$38.8M Buy
1,250,567
+1,845
+0.1% +$52.7K 1.24% 31
2015
Q4 		$38.2M Sell
1,248,722
-892
-0.1% -$28.1K 1.18% 32
2015
Q3 		$37.2M Sell
1,249,614
-52,700
-4% -$1.69M 1.17% 29
2015
Q2 		$41.4M Sell
1,302,314
-870
-0.1% -$28.4K 1.16% 31
2015
Q1 		$43.4M Hold
1,303,184
– – 1.16% 30
2014
Q4 		$38.5M Hold
1,303,184
– – 1.01% 40
2014
Q3 		$36.6M Hold
1,303,184
– – 0.98% 41
2014
Q2 		$36.7M Hold
1,303,184
– – 0.95% 44
2014
Q1 		$39.7M Sell
1,303,184
-5,059
-0.4% -$151K 1.04% 34
2013
Q4 		$38M Hold
1,308,243
– – 0.97% 42
2013
Q3 		$35.7M Hold
1,308,243
– – 0.95% 40
2013
Q2 		$34.8M Buy
+1,308,243
New +$36.1M 0.95% 40

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Saturna Capital's PFE Position: Q1 2025 in Review

Saturna Capital sold out of Pfizer (PFE) in Q1 2025, closing a stake of 442,650 shares — an estimated $11.7M sold.

Saturna Capital first reported a position in PFE in Q2 2013 and held it in 47 quarters. The position peaked at $68.5M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Saturna Capital reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Saturna Capital sold 442,650 Pfizer shares in Q1 2025, an estimated $11.7M.
  • Saturna Capital first reported a position in Pfizer in Q2 2013 and held it in 47 quarters.
  • Saturna Capital's Pfizer position peaked at $68.5M in Q4 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Saturna Capital's 13F filing for Q1 2025, filed 2 May 2025.